We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Chinese Agency Approves Image-Guided Radiotherapy System

By HospiMedica International staff writers
Posted on 10 May 2011
A fully integrated, image-guided radiotherapy system has been designed to treat tumors with great speed and accuracy--including tumors that move during treatment as the patient breathes in and out.

Varian Medical Systems, Inc. More...
(Palo Alto, CA, USA), a manufacturer of medical technology for treating cancer with radiotherapy, reported that the Chinese State Food and Drug Administration (SFDA) has approved its TrueBeam system for image-guided radiotherapy.

TrueBeam features many technical innovations that greatly synchronize imaging, patient positioning, motion management, and treatment delivery. With its high-intensity mode, TrueBeam can deliver very high doses rapidly and accurately, more than twice as fast as earlier generations of technology. This makes it possible to considerably shorten treatments, and to improve precision by leaving less time for tumor motion during dose delivery. It also enables clinics to offer advanced treatment to more cancer patients each day.

"Intelligent" automation further speeds treatments and makes the technology easier to use, with an up to five-fold reduction in the number of steps needed for imaging, positioning and treating patients. A standard intensity-modulated treatment that would typically take 10 minutes can be completed in less than two minutes.

Varian first introduced the TrueBeam system in the United States in April 2010. It is now in use at more than 40 treatment centers across the United States and Europe to target tumors of the lung, liver, pancreas, head and neck, and many other organs. "The TrueBeam system is Varian's most advanced offering for dealing with tumor motion, which makes it especially well-suited for treating cancer of the lung and liver, two types that occur commonly in China," said Tom Duffy, head of Varian's oncology systems business in Asia. "With its combination of advanced real-time imaging, high-intensity mode, and gated RapidArc for synchronizing treatment with tumor motion, it's an excellent device for delivering high-dose hypofractionated radiotherapy. There is a growing body of research that indicates this is an especially effective way to treat liver and lung cancer."

Related Links:

Varian Medical Systems




Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Syringe Pump
SP50 Series
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.